March 27, 2019
Hilton Vienna Danube Waterfront
Vienna, Austria



Since the recent reform of China’s drug approval process, clinical trials and new drug approval in China has speeded up. In 2017 alone, 34 pharma products and 5 biotech products were approved, making a record high in the history. It opened the door for drug development companies around the world to the Chinese market and also ignited license-in interest from Chinese public pharma companies.

China Focus @ Europe Vienna is bringing together investors and pharma leaders from China and healthcare innovators for an exclusive event designed to inspire, educate and foster cross-border investment and collaboration in leading biopharma innovations from around the world. The forum features premier 1-to-1 networking opportunities prior to and during the forum.

Mar 27, 2019    Hilton Vienna Danube Waterfront Vienna, Austria





at Previous China Focus Events


European Countries


Executive Level Attendees

Chinese Companies and Investors

One-to-one meetings

Company Presentations






Plenary session: Grand Waterfront Hall 1


8:00 – 9:00Check-in
9:00 – 9:10Opening Remarks
9:10 – 9:40

Keynote: Status and trends of Chinese investment in Europe

Csaba Wolf – Business Development Director, Deloitte

9:40 – 10:30

PANEL 1: Opportunities and challenges with China-Europe partnership in life science and healthcare

Andy Li – Founding Partner, BioSense Global LLC

Dong Chen – Director and China head of business development, Jiangsu Hengrui Pharmaceutical

Katherine Cohen – Venture Partner, Panacea Venture

Olivier Reinhard – VP Head of business development transactions for China and Emerging Markets, Sanofi

10:30 – 10:40Break
10:40 – 11:10

Cross-border Camp Talk: Strategic considerations for obtaining patents on your intellectual property assets

Daniel J. Nevrivy – Founder, Nevrivy Patent Law Group P.L.L.C.

11:10 – 12:00

PANEL 2: European innovations meet China resources

Aamir Shahzad – President, European Society for Translational Medicine

Dianna Qian – Partner, Pivotal bioVenture Partners China

Fei Tian – Principle, Vesalius Biocapital

Gottfried Köhler – Chair of Advisory Board, European Society for Translational Medicine

James Warr – Associate, Greenhill & Co.

12:00 – 13:30Lunch
13:30 – 14:20

PANEL 3: Oversea strategies of Chinese innovative biotech & pharma

Tom Du – Medical Partner, Shenzhen Share Capital

Jun Bao – President and CEO, Impact Therapeutics

Qingping Zeng – President and CEO, Fosun Orinove

Ping Cao – VP business development, Henlius Biotech

Sara Chen – Head of business development, Genfleet Therapeutics

14:20 – 15:30Company Presentation
15:30 – 15:40Break
15:40 – 16:10

Cross-border Camp Talk: Valuation of your licensing asset – deal or no deal

Patrik Frei – CEO, Venture Valuation AG

16:10- 17:00

PANEL 4: Partnering opportunities with Chinese pharma

Echo Hindle-Yang – CEO, MSQ Ventures

Qun Dang – VP Global head of business development, Qilu Pharmaceutical

John Xu – CEO and co-founder, Jemincare Therapeutics

Carlos de Sousa – CEO, Immunicum AB

18:00 – 20:00MyBioGate China Focus Dinner (Separate registration required)



Download Sample Attendee List from past China Focus events

Download Program from past China Focus events



Participating Companies

Henlius Biotech


Merck Sharp & Dohme

Biosense Global LLC

Shenzhen Share Capital

Humphries Pharmaceutical Consulting

Pivotal bioVenture Partners China

Panacea Venture

Vesalius Biocapital

Impact Therapeutics

Deloitte Co. Ltd.

Jiangsu Hengrui Pharmaceutical

Fosun Orinove

Tasly Pharmaceutical

Luye Pharma Group

Qilu Pharmaceutical

Buchang Pharma

Simcere Pharmaceutical Group

Jemincare Therapeutics

Weigao Holding Company

Harbin Pharmaceutical group

Fosun Pharma

MSQ Ventures



Csaba Wolf

Business Development Director


Katherine Cohen

Venture Partner
Panacea Venture

Andy Li

Founding Partner
Biosense Global LLC

Olivier Reinhard

VP, BD&L for China and emerging markets


Ping Cao

VP business development
Henlius Biotech

Dong Chen

Director and China head of business development
Jiangsu Hengrui Pharmaceutical

Jun Bao

President and CEO
Impact Therapeutics

Qun Dang

VP, Global head of business development
Qilu Pharmaceutical

Qingping Zeng

President and CEO
Fosun Orinove

Dianna Qian

Pivotal bioVenture Partners China

John Xu

CEO and co-founder
Jemincare Therapeutics

Tom Du

Medical Partner
Shenzhen Share Capital

Echo Hindle-Yang

CEO & Founder
MSQ Ventures

Fei Tian

Vesalius Biocapital

Sara Chen

Head of business development
Genfleet Therapeutics

James Warr

Greenhill & Co.

Aamir Shahzad

European Society for Translational Medicine

Gottfried Köhler

Chair, Advisory board
European Society for Translational Medicine


11 + 9 =

Registration, Sponsorship and Collaboration (China)

Youwen (Allen) Dai

[email protected]

Registratin, Sponsorship and Collaboration (U.S. and Europe)

Xinxin Li

[email protected]

Registration, Group Delegation and Presenting Companies (U.S.)

Han Yan

[email protected]



Hilton Vienna Danube Waterfront


Handelskai 269, 1020 VIENNA, Austria

TEL: +43-1-72777

FAX: +43-1-72777

Hotel website: